Viomi Technology Co., Ltd Reports First Half 2025 Unaudited Financial Results GlobeNewswire November 10, 2025 GUANGZHOU, China, Nov. 10, 2025 (GLOBE NEWSWIRE) — Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced its unaudited financial results for the six months ended June […]
NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form-2?prid=176380&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
A news report from China Daily: At theQuehua Ecological and Cultural Zone in Jinan Start-up Area for Growth Drivers Transformation, Shandong Province, French youth RIVOIRE Oceane Anna, along with her peers, tried her hand at paper-cutting, successfully crafting the Chinese characters for “nian nian you yu,” a traditional auspicious phrase symbolizing abundance and surplus. https://mma.prnewswire.com/media/2818348/image_5025282_29560393.jpg
— The world's largest tech and AI show brought groundbreaking innovations in healthcare, neurotech and life sciences to the forefront — M42, Cleveland Clinic, SandboxAQ, Mammoth Biosciences, Paradromics and Liquid AI steered the conversations on faster, more effective healthcare discoveries and industry transformation The convergence of AI, quantum computing, and biosciences is propelling the global
— Proof-of-concept established for LEU011 in the treatment of relapsed/refractory solid tumours — LEU011 has been well tolerated, with disease control observed in multiple patients at lowest dose evaluated to date — Enrolment continues in dose-escalation segment of the AERIAL trial with additional data for LEU011 anticipated during the first half of 2026 — Poster
NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=176379&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
MALMÖ, SE / ACCESS Newswire / November 10, 2025 / Ascelia Pharma (STO:ACE) – Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced the filing of a new patent application for its first-in-class orphan liver imaging drug Orviglance®. In line with the strategy
https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to
https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of common stock of Cepton, Inc. (NASDAQ: CPTN) between July 29, 2024 and January 6, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. So what: If you purchased or sold Cepton, Inc.
https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the “Class Period”), of the importantNovember 17, 2025 lead plaintiff deadline. So what: If you purchased Cytokineticscommon stock during the Class Period you may